Literature DB >> 12192061

Dyrk1A haploinsufficiency affects viability and causes developmental delay and abnormal brain morphology in mice.

Vassiliki Fotaki1, Mara Dierssen, Soledad Alcántara, Salvador Martínez, Eulàlia Martí, Caty Casas, Joana Visa, Eduardo Soriano, Xavier Estivill, Maria L Arbonés.   

Abstract

DYRK1A is the human orthologue of the Drosophila minibrain (mnb) gene, which is involved in postembryonic neurogenesis in flies. Because of its mapping position on chromosome 21 and the neurobehavioral alterations shown by mice overexpressing this gene, involvement of DYRK1A in some of the neurological defects of Down syndrome patients has been suggested. To gain insight into its physiological role, we have generated mice deficient in Dyrk1A function by gene targeting. Dyrk1A(-/-) null mutants presented a general growth delay and died during midgestation. Mice heterozygous for the mutation (Dyrk1A(+/-)) showed decreased neonatal viability and a significant body size reduction from birth to adulthood. General neurobehavioral analysis revealed preweaning developmental delay of Dyrk1A(+/-) mice and specific alterations in adults. Brains of Dyrk1A(+/-) mice were decreased in size in a region-specific manner, although the cytoarchitecture and neuronal components in most areas were not altered. Cell counts showed increased neuronal densities in some brain regions and a specific decrease in the number of neurons in the superior colliculus, which exhibited a significant size reduction. These data provide evidence about the nonredundant, vital role of Dyrk1A and suggest a conserved mode of action that determines normal growth and brain size in both mice and flies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12192061      PMCID: PMC135639          DOI: 10.1128/MCB.22.18.6636-6647.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  37 in total

1.  Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment.

Authors:  D C Rogers; E M Fisher; S D Brown; J Peters; A J Hunter; J E Martin
Journal:  Mamm Genome       Date:  1997-10       Impact factor: 2.957

Review 2.  The genetics of visual system development in Drosophila: specification, connectivity and asymmetry.

Authors:  T Cutforth; U Gaul
Journal:  Curr Opin Neurobiol       Date:  1997-02       Impact factor: 6.627

3.  Possible narrowed assignment of the loci of monosomy 21-associated microcephaly and intrauterine growth retardation to a 1.2-Mb segment at 21q22.2.

Authors:  N Matsumoto; H Ohashi; M Tsukahara; K C Kim; E Soeda; N Niikawa
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

4.  Calretinin in the mouse superior colliculus originates from retinal ganglion cells.

Authors:  F Gobersztejn; L R Britto
Journal:  Braz J Med Biol Res       Date:  1996-11       Impact factor: 2.590

5.  A human homologue of Drosophila minibrain (MNB) is expressed in the neuronal regions affected in Down syndrome and maps to the critical region.

Authors:  J Guimerá; C Casas; C Pucharcòs; A Solans; A Domènech; A M Planas; J Ashley; M Lovett; X Estivill; M A Pritchard
Journal:  Hum Mol Genet       Date:  1996-09       Impact factor: 6.150

6.  Functional screening of 2 Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome.

Authors:  D J Smith; M E Stevens; S P Sudanagunta; R T Bronson; M Makhinson; A M Watabe; T J O'Dell; J Fung; H U Weier; J F Cheng; E M Rubin
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

7.  Human minibrain homologue (MNBH/DYRK1): characterization, alternative splicing, differential tissue expression, and overexpression in Down syndrome.

Authors:  J Guimera; C Casas; X Estivill; M Pritchard
Journal:  Genomics       Date:  1999-05-01       Impact factor: 5.736

8.  Isolation of human and murine homologues of the Drosophila minibrain gene: human homologue maps to 21q22.2 in the Down syndrome "critical region".

Authors:  W J Song; L R Sternberg; C Kasten-Sportès; M L Keuren; S H Chung; A C Slack; D E Miller; T W Glover; P W Chiang; L Lou; D M Kurnit
Journal:  Genomics       Date:  1996-12-15       Impact factor: 5.736

9.  The murine Dyrk protein maps to chromosome 16, localizes to the nucleus, and can form multimers.

Authors:  W J Song; S H Chung; D M Kurnit
Journal:  Biochem Biophys Res Commun       Date:  1997-02-24       Impact factor: 3.575

10.  minibrain: a new protein kinase family involved in postembryonic neurogenesis in Drosophila.

Authors:  F Tejedor; X R Zhu; E Kaltenbach; A Ackermann; A Baumann; I Canal; M Heisenberg; K F Fischbach; O Pongs
Journal:  Neuron       Date:  1995-02       Impact factor: 17.173

View more
  121 in total

Review 1.  Trisomy 21 and early brain development.

Authors:  Tarik F Haydar; Roger H Reeves
Journal:  Trends Neurosci       Date:  2011-12-09       Impact factor: 13.837

Review 2.  The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation.

Authors:  Lars P Van Der Heide; Marco F M Hoekman; Marten P Smidt
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

3.  Distinctive Phenotypic Abnormalities Associated with Submicroscopic 21q22 Deletion Including DYRK1A.

Authors:  R Oegema; A de Klein; A J Verkerk; R Schot; B Dumee; H Douben; B Eussen; L Dubbel; P J Poddighe; I van der Laar; W B Dobyns; P J van der Spek; M H Lequin; I F M de Coo; M-C Y de Wit; M W Wessels; G M S Mancini
Journal:  Mol Syndromol       Date:  2010-09-14

4.  The proteins of human chromosome 21.

Authors:  Katheleen Gardiner; Alberto C S Costa
Journal:  Am J Med Genet C Semin Med Genet       Date:  2006-08-15       Impact factor: 3.908

5.  DYRK1A autophosphorylation on serine residue 520 modulates its kinase activity via 14-3-3 binding.

Authors:  Mónica Alvarez; Xavier Altafaj; Sergi Aranda; Susana de la Luna
Journal:  Mol Biol Cell       Date:  2007-01-17       Impact factor: 4.138

6.  The Down syndrome critical region regulates retinogeniculate refinement.

Authors:  Martina Blank; Peter G Fuerst; Beth Stevens; Navid Nouri; Lowry Kirkby; Deepti Warrier; Ben A Barres; Marla B Feller; Andrew D Huberman; Robert W Burgess; Craig C Garner
Journal:  J Neurosci       Date:  2011-04-13       Impact factor: 6.167

7.  LPS-Induced Inflammation Abolishes the Effect of DYRK1A on IkB Stability in the Brain of Mice.

Authors:  Alizée Latour; Yuchen Gu; Nadim Kassis; Fabrice Daubigney; Catherine Colin; Blandine Gausserès; Sandrine Middendorp; Jean-Louis Paul; Valérie Hindié; Jean-Christophe Rain; Jean-Maurice Delabar; Eugene Yu; Mariona Arbones; Michel Mallat; Nathalie Janel
Journal:  Mol Neurobiol       Date:  2018-05-30       Impact factor: 5.590

8.  Nonprimed and DYRK1A-primed GSK3 beta-phosphorylation sites on MAP1B regulate microtubule dynamics in growing axons.

Authors:  Timothy M E Scales; Shen Lin; Michaela Kraus; Robert G Goold; Phillip R Gordon-Weeks
Journal:  J Cell Sci       Date:  2009-06-23       Impact factor: 5.285

9.  Otud7a Knockout Mice Recapitulate Many Neurological Features of 15q13.3 Microdeletion Syndrome.

Authors:  Jiani Yin; Wu Chen; Eugene S Chao; Sirena Soriano; Li Wang; Wei Wang; Steven E Cummock; Huifang Tao; Kaifang Pang; Zhandong Liu; Fred A Pereira; Rodney C Samaco; Huda Y Zoghbi; Mingshan Xue; Christian P Schaaf
Journal:  Am J Hum Genet       Date:  2018-02-01       Impact factor: 11.025

10.  Evaluation of substituted 6-arylquinazolin-4-amines as potent and selective inhibitors of cdc2-like kinases (Clk).

Authors:  Bryan T Mott; Cordelle Tanega; Min Shen; David J Maloney; Paul Shinn; William Leister; Juan J Marugan; James Inglese; Christopher P Austin; Tom Misteli; Douglas S Auld; Craig J Thomas
Journal:  Bioorg Med Chem Lett       Date:  2009-10-03       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.